Robert P. Lenk, Director at PLUS THERAPEUTICS, INC. (PSTV), bought 4,167 shares at $2.04 ($9K) on 2024-05-08, disclosed to the SEC on 2024-05-10.
Open-market purchase of $9k PSTV by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| PSTV | BUY | 2023-11-15 | $9K | — | Filing → |
| PSTV | BUY | 2023-11-13 | $15K | — | Filing → |
| PSTV | BUY | 2023-11-08 | $12K | — | Filing → |